Serina Therapeutics, Inc. (SER)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 1.5M 3M 4.5M Q1 '23: 59K Q2 '23: 54K Q3 '23: 74K Q4 '23: 3.2M Q1 '24: 3.1M Q2 '24: 3.2M Q3 '24: 3.2M Q4 '25: 130K Q1 '23 Q2 '23 Q3 '23 Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '25

Gross Profit TTM

0 35K 70K 105K Q1 '22: 76K Q2 '22: 58K Q3 '22: 40K Q4 '22: 21K Q1 '23: 26K Q2 '23: 24K Q3 '23: 54K Q4 '23: 102K Q1 '22 Q2 '22 Q3 '22 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23

Operating Income TTM

-27M -18M -9M 0 9M 18M 27M Q1 '24: -4.5M Q2 '24: -7.4M Q3 '24: -11.3M Q4 '24: -17M Q1 '25: -20.6M Q2 '25: -22.3M Q3 '25: -23.4M Q4 '25: -24M Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25

Net Income TTM

-24M -16M -8M 0 8M 16M 24M Q3 '24: -7.3M Q4 '24: -11.1M Q1 '25: -939K Q2 '25: -12.6M Q3 '25: -18.6M Q4 '25: -19.2M Q1 '26: -21.3M Q2 '26: -21.2M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 15K 30K 45K Q1 '22: 17K Q2 '22: 10K Q3 '22: 13K Q4 '22: 13K Q1 '23: 13K Q2 '23: 12K Q3 '23: 40K Q4 '23: 40K Q1 '22 Q2 '22 Q3 '22 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23

Operating Cash Flow TTM

-24M -16M -8M 0 8M 16M 24M Q3 '24: -12.4M Q4 '24: -17.1M Q1 '25: -19.9M Q2 '25: -15.6M Q3 '25: -16.5M Q4 '25: -18M Q1 '26: -18.2M Q2 '26: -21.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-24M -16M -8M 0 8M 16M 24M Q4 '20: -7.8M Q4 '24: -17.2M Q1 '25: -19.9M Q2 '25: -15.7M Q3 '25: -16.6M Q4 '25: -18M Q1 '26: -18.3M Q2 '26: -21.2M Q4 '20 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 6M 12M 18M Q1 '24: 2.8M Q2 '24: 10.2M Q3 '24: 10.8M Q1 '25: 9.8M Q2 '25: 10M Q3 '25: 10.3M Q1 '26: 12M Q2 '26: 16.4M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q3 '20: -0.30 Q4 '20: -0.29 Q1 '21: -0.27 Q2 '24: -4.48 Q3 '24: -4.58 Q4 '25: -1.91 Q1 '26: -2.00 Q2 '26: -1.89 Q3 '20 Q4 '20 Q1 '21 Q2 '24 Q3 '24 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.